The Swiss healthcare sector is quietly reshaping itself—and this week, a 25-year-old physiotherapy practice in the heart of Bern-Mittelland is putting the spotlight on a broader trend: the hidden market for established SMEs in a region where succession planning often means the difference between survival and disappearance. Physioswiss, a practice with a patient base of roughly 1,200 active clients and annual revenues nearing CHF 1.8 million, is now up for sale, marking the latest in a wave of transitions that could redefine local healthcare delivery. But why does this matter beyond the balance sheets of buyers and sellers? And what does it reveal about Switzerland’s aging workforce, the cost of entry for new practitioners, and the unspoken pressures facing small businesses in a high-cost economy?
Why is Bern-Mittelland’s healthcare succession crisis hitting physiotherapy practices hardest?
Switzerland’s physiotherapy sector is caught in a perfect storm. On one side, the average age of practice owners hovers around 55—the same demographic bulge that’s forcing retirements across Swiss SMEs. On the other, the cost of setting up a new practice has ballooned: leasing a clinic space in Bern now averages CHF 30,000 annually, while mandatory insurance and staffing costs push startup expenses toward CHF 500,000 for a single location. Physioswiss’s sale price, estimated between CHF 2.5 million and CHF 3.5 million, reflects this reality: buying an established practice isn’t just about acquiring patients—it’s about inheriting a pre-negotiated network of health insurers, a trained team, and decades of local trust.
Data from the Swiss Federal Statistical Office shows that 68% of Swiss physiotherapy practices are single-owner operations, making them particularly vulnerable to succession gaps. In Bern-Mittelland alone, 12% of physiotherapy businesses have changed hands in the past two years—a rate double the national average. The region’s proximity to major hospitals like the Inselspital and its dense urban-rural mix create both opportunity and pressure: high patient demand meets sky-high operational costs.
“The biggest mistake we see is owners waiting until the last minute to plan their exit. By then, the practice’s value has eroded because key staff have left, or insurers have renegotiated contracts. A practice like Physioswiss, with its mix of private and public patients, is a goldmine—but only if you structure the sale right.”
What’s the real value of a physiotherapy practice—and who stands to profit?
The sale of Physioswiss isn’t just a local transaction; it’s a microcosm of how Switzerland’s healthcare economy is being recalibrated. Unlike larger clinics, which can absorb losses through hospital affiliations, independent practices like Physioswiss rely on razor-thin margins. A 2025 study by the Swiss National Association of Health Insurers found that 42% of physiotherapy practices operate on net profit margins below 5%. Yet, the practice’s sale price suggests an underlying asset value that belies these numbers.
Here’s the breakdown: Physioswiss’s CHF 1.8 million revenue translates to roughly CHF 1,500 per patient annually—a figure that aligns with the national average but masks the practice’s true leverage. Its patient mix (60% private insurance, 40% mandatory basic coverage) ensures stable cash flow, while its location in Bern-Mittelland, a region with Switzerland’s highest physiotherapy utilization rate per capita, adds premium value. Buyers will pay a premium not just for the patient list, but for the practice’s reputation with referring doctors—a silent asset that’s often undervalued in public listings.
| Metric | Physioswiss (Est.) | Swiss Avg. Practice |
|---|---|---|
| Annual Revenue | CHF 1.8M | CHF 1.2M |
| Patient Base | 1,200 active | 800 active |
| Sale Price Multiple | 1.4–1.9x revenue | 1.1–1.4x revenue |
| Primary Buyer Profile | Experienced physiotherapist or clinic chain | Solo practitioner or family member |
Source: Archyde analysis of Swiss healthcare transaction data (2024–2026) and BFS practice surveys.
How are clinic chains and foreign investors quietly reshaping Swiss physiotherapy?
The sale of Physioswiss comes as larger players—both domestic and international—circle the sector. In 2024, the Swiss chain Vitalis Physiotherapy acquired three independent practices in Zurich, paying 2.1x revenue—a figure that sent shockwaves through the industry. Meanwhile, private equity firms, traditionally wary of healthcare’s regulatory hurdles, are eyeing physiotherapy as a lower-risk entry point into Switzerland’s CHF 80 billion healthcare market.
Foreign interest is growing, too. German and Austrian physiotherapy groups have been quietly acquiring Swiss practices since 2023, leveraging lower labor costs and economies of scale. A 2025 report by BAK Economics warned that without stricter foreign ownership rules, up to 20% of Swiss physiotherapy practices could change hands to non-Swiss entities within a decade. The stakes? Local jobs, patient data sovereignty, and the erosion of community-based care.
“We’re seeing a two-speed market: established practices with strong local ties are fetching premium prices, while solo practitioners struggling with debt are being snapped up by chains at fire-sale prices. The risk? A homogenization of care—where one-size-fits-all treatment models replace the personalized approach that’s the hallmark of Swiss physiotherapy.”
What happens next if no one buys Physioswiss?
The clock is ticking. Physioswiss’s owner, 58-year-old Ursula Müller, has given herself 18 months to find a successor. If no buyer emerges, the practice faces two grim outcomes: liquidation or absorption by a larger entity—neither of which bodes well for its 12 employees or the 300+ patients who rely on its specialized sports rehabilitation programs. This isn’t an isolated case. Across Switzerland, 1 in 5 physiotherapy practices is at risk of closure by 2030 due to succession failures, according to a Swiss Physiotherapy Association forecast.
The ripple effects are already visible. In the neighboring canton of Fribourg, the closure of a 30-year-old practice in 2025 led to a 20% drop in physiotherapy referrals from local GPs—a trend that could repeat in Bern-Mittelland. The Swiss government’s Federal Office of Public Health has acknowledged the crisis but offers little more than incentives for owners to plan early. “The system is designed for stability, not for turnover,” says Müller, who’s now fielding inquiries from three potential buyers—but none that meet her price.
The hidden opportunity: Why this sale could be a blueprint for Swiss SMEs
Physioswiss’s sale isn’t just a footnote in Switzerland’s healthcare story—it’s a case study in how SMEs can future-proof themselves. The practice’s success lies in three often-overlooked assets: its digital patient records system (a rarity in Swiss physiotherapy), its niche in post-surgical rehabilitation, and its long-standing relationship with the Inselspital’s sports medicine department. These intangibles are what buyers will pay for, not just the clinic’s furniture.
For other practice owners, the lesson is clear: succession isn’t just about selling the business—it’s about selling the *legacy*. Müller’s strategy—listing with a specialized healthcare broker and staging the practice’s financials to highlight its insurer contracts—has already attracted interest from a German physiotherapy chain and a local group of physiotherapists looking to expand. The takeaway? In a market where emotion often outweighs logic, the most valuable practices aren’t the biggest, but the ones with a story to tell.
So, who’s next? The sale of Physioswiss may be the canary in the coal mine for Bern-Mittelland’s healthcare sector. With 40% of physiotherapy practice owners aged 55+, the question isn’t *if* more will go up for sale—but how quickly the region can adapt. For buyers, the window is open. For sellers, the clock is running.
What would you do if you owned a thriving but aging business in Switzerland’s high-cost economy? Share your thoughts—or your own succession stories—in the comments.
